The parent of Dutch x-ray developer Oldelft issued a warning last month that it expects to post a net loss for 1998. Delft Instruments said that restructuring charges were the main factor in the loss. Also, orders that were expected for the end of the
The parent of Dutch x-ray developer Oldelft issued a warning last month that it expects to post a net loss for 1998. Delft Instruments said that restructuring charges were the main factor in the loss. Also, orders that were expected for the end of the year failed to materialize.
Delft expects to post an after-tax operating loss of $1.41 million for the year, compared with a profit of $7.1 million in 1997. After one-time gains and charges, Delft will post an after-tax net loss of $21.6 million. Delft recorded a one-time gain due to the sale of its Enraf-Nonius business, but that benefit was outweighed by restructuring costs.
Delft began reorganizing in October to return to profitability. The restructuring included job cuts and the sale of unprofitable businesses. Delft plans to keep its ultrasound activities as well as Oldelft, which will focus on digital products such as its Digidelca-C digital chest system. Oldelfts R&D, sales, and marketing activities were folded into those of Nucletron, which resulted in the loss of about 40 Oldelft jobs.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.